ARCHIVES

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

This article is from The Cancer Letter archive.

Vol. 09 No. 01 | January 7, 1983

Download PDF Visit The Full Archive

Related Articles

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

Smoking & Health Contractors Meet

July 11, 1975

In Brief: ACA Executive Committee Votes to Move HQ Out Of New York; Davis Establishes Office In D.C.

April 17, 1987

Fisher, NSABP Executive Committee, File Injunction Seeking Herberman’s Removal

August 12, 1994

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees

January 3, 1992